BACKGROUND:: Recent antihypertensive treatment guidelines recommend greater use of
combination therapies. OBJECTIVES:: The primary objective of this study was to determine …

BACKGROUND:: One third of patients treated for hypertension attain adequate blood
pressure (BP) control, and multidrug regimens are often required. Given the lifelong nature …

Abstract▲ Amlodipine/valsartan/hydrochlorothiazide (HCTZ) is a fixed-dose combination of
the well established antihypertensive agents amlodipine (a calcium channel antagonist) …

Objective: This study compared the efficacy and tolerability of two combination regimens of
valsartan and hydrochlorothiazide (HCTZ) with valsartan monotherapy in patients with …

A multicenter, randomized double-blind study of valsartan/hy... : Journal of Hypertension A
multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination …

BACKGROUND:: Combination therapy with at least 2 antihypertensive agents is usually
needed to achieve appropriate blood pressure (BP) control in patients with isolated or …

Abstract Objective: The EXCITE (clinical EXperienCe of amlodIpine and valsarTan in
hypErtension) study was designed to evaluate the effectiveness, tolerability and adherence …

Objectives: To determine whether blood pressure (BP) control in hypertensive patients
achieved with combination drug therapy provides the same cardiovascular benefits as with …

Introduction An 8-week trial of amlodipine/valsartan/hydrochlorothiazide (Aml/Val/HCTZ) for
moderate or severe hypertension demonstrated more-pronounced blood pressure (BP) …

Objective: This study compares the antihypertensive efficacy and tolerability of valsartan, a
novel angiotensin II antagonist, given with hydrochlorothiazide (HCTZ) vs placebo or vs …